Showing results 1 to 2 of 2
Issue Date | Title | Journal Title |
---|---|---|
2024 | A Phase II Open-Label Randomized Clinical Trial of Preoperative Durvalumab or Durvalumab plus Tremelimumab in Resectable Head and Neck Squamous Cell Carcinoma | CLINICAL CANCER RESEARCH |
2023 | Brain Tumor Classification by Methylation Profile | JOURNAL OF KOREAN MEDICAL SCIENCE |